Amol N.S. Rakkar
- Oncology top 10%
- Molecular Biology
- Genetics
- Biotechnology top 10%
- Cancer Research
- Topics
- Cancer-related Molecular Pathways (6 papers)Cancer Research and Treatments (3 papers)Acute Myeloid Leukemia Research (2 papers)
- Cited by
- OncologyBiotechnologyCancer Research
- Journals
- BloodJNCI Journal of the National Cancer InstituteBiochemical and Biophysical Research Communications
- Partner nations
- United States
In The Last Decade
Amol N.S. Rakkar
9 papers receiving 471 citations
Peers
Comparison fields: 5 of 60
- Oncology 298
- Molecular Biology 269
- Genetics 87
- Biotechnology 85
- Cancer Research 76
Countries citing papers authored by Amol N.S. Rakkar
This map shows the geographic impact of Amol N.S. Rakkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amol N.S. Rakkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amol N.S. Rakkar more than expected).
Fields of papers citing papers by Amol N.S. Rakkar
This network shows the impact of papers produced by Amol N.S. Rakkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amol N.S. Rakkar. The network helps show where Amol N.S. Rakkar may publish in the future.
Co-authorship network of co-authors of Amol N.S. Rakkar
This figure shows the co-authorship network connecting the top 25 collaborators of Amol N.S. Rakkar. A scholar is included among the top collaborators of Amol N.S. Rakkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amol N.S. Rakkar. Amol N.S. Rakkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 3 | |
| 3 | 44 | |
| 4 | 19 | |
| 5 | 48 | |
| 6 | 17 | |
| 7 | 31 | |
| 8 | A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: a gene therapy approach for drug-resistant cancers. | 34 |
| 9 | Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. | 284 |
About Amol N.S. Rakkar
Amol N.S. Rakkar is a scholar working on Biotechnology, Hematology and Oncology, having authored 9 papers that have together received 484 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Cancer Research and Treatments (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Oncology (298 citations), Biotechnology (85 citations) and Cancer Research (76 citations). Amol N.S. Rakkar has collaborated with scholars based in United States. Frequent co-authors include Prem Seth, Kenneth H. Cowan, Zheng Li, Y. Katayose, Zhuangwu Li, Min Kim, Dai Katayose, Yu Katayose, Naga Shanmugam and Qingdi Li. Their work appears in journals such as Blood, JNCI Journal of the National Cancer Institute and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.